Results 291 to 300 of about 934,333 (350)
Some of the next articles are maybe not open access.
Seretide for obstructive lung disease
Expert Opinion on Pharmacotherapy, 2002Seretide (Advair [North America], GlaxoSmithKline) is an inhaler combination formulation intended for the maintenance therapy of obstructive airways disease. Seretide was developed and made available initially as three multi-dose, dry powder inhaler formulations delivering 50 microg/puff of the long acting beta(2) agonist salmeterol and either 100, 250
openaire +2 more sources
2023
Abstract Obstructive airway diseases are a commonly tested topic in anesthesia for both the written and oral examinations and are separated into upper airway (obstructive sleep apnea [OSA]), tracheobronchial (foreign body), and parenchymal disorders (mediastinal masses). Obstructive disorders have resistance to airflow which leads to air
Bryan J. Hierlmeier, Anesh Rugnath
openaire +1 more source
Abstract Obstructive airway diseases are a commonly tested topic in anesthesia for both the written and oral examinations and are separated into upper airway (obstructive sleep apnea [OSA]), tracheobronchial (foreign body), and parenchymal disorders (mediastinal masses). Obstructive disorders have resistance to airflow which leads to air
Bryan J. Hierlmeier, Anesh Rugnath
openaire +1 more source
1989
Obstructive lung disease like chronic bronchitis, asthma, pulmonary emphysema and their numerous combinations result from acute or chronic influence of noxious factors on the structures of the respiratory system. While in chronic bronchitis and asthma the conducting airways are affected, in pulmonary emphysema the integrity of the pulmonary parenchyma ...
openaire +2 more sources
Obstructive lung disease like chronic bronchitis, asthma, pulmonary emphysema and their numerous combinations result from acute or chronic influence of noxious factors on the structures of the respiratory system. While in chronic bronchitis and asthma the conducting airways are affected, in pulmonary emphysema the integrity of the pulmonary parenchyma ...
openaire +2 more sources
Pulmonary Hemodynamics in Obstructive Lung Disease
Diseases of the Chest, 1968SUMMARY Various aspects of pulmonary hemodynamics were studied in 34 emphysema patients: (a) when the cardiac output was interpreted on the basis of each patient's age, the majority (85 per cent) showed either normal or high output, while the remainder (15 per cent) had a definitely low output.
T P, Lim, W E, Brownlee
openaire +2 more sources
Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 2009AbstractPurposeUsing hospitalization always has been seen as a solid measurement for exacerbation in pharmacoepidemiology, but might lead to an underestimation of disease exacerbation because of a trend towards outpatient care. The aim of this study was to quantify the incidence of different exacerbation markers in obstructive lung disease and to ...
Velthove, K.J. +4 more
openaire +3 more sources
Ventilatory Strategies in Obstructive Lung Disease
Seminars in Respiratory and Critical Care Medicine, 2014Chronic obstructive pulmonary disease (COPD) is characterized by expiratory flow limitation (EFL) due to progressive airflow obstruction. The various mechanisms that cause EFL are central to understanding the physiopathology of COPD. At the end of expiration, dynamic inflation may occur due to incomplete emptying the lungs.
Francisco José, Parrilla +3 more
openaire +2 more sources
CHRONIC OBSTRUCTIVE LUNG DISEASE
The Lancet, 1971N G, Sanerkin, K N, Palmer
openaire +4 more sources
MECHANICAL VENTILATION IN OBSTRUCTIVE LUNG DISEASE
Clinics in Chest Medicine, 1996This article reviews selected topics relevant to the use of mechanical ventilation in patients with severe airflow obstruction. Areas discussed include the bedside assessment of respiratory system mechanics, the ventilatory determinants of dynamic pulmonary hyperinflation, the role of controlled hypoventilation with permissive hypercapnia, and the ...
openaire +2 more sources
Bronchodilator Therapy in Obstructive Lung Disease
Allergy and Asthma Proceedings, 1985In recent years the management of patients with obstructive lung disease has been greatly simplified by the introduction of highly selective long-acting beta adrenergic agonists, slow release theophylline preparations and locally active anticholinergic agents. The beta adrenergic compounds are the most potent and many feel that they should be the first
openaire +2 more sources
2018
Mechanical ventilation is often used in the setting of acute exacerbations of obstructive lung diseases like asthma and chronic obstructive pulmonary disease (COPD). These disorders are characterized by increased airway resistance secondary to bronchospasm and airway inflammation, collapse, and remodeling, often leading to inefficient exhalation and ...
openaire +1 more source
Mechanical ventilation is often used in the setting of acute exacerbations of obstructive lung diseases like asthma and chronic obstructive pulmonary disease (COPD). These disorders are characterized by increased airway resistance secondary to bronchospasm and airway inflammation, collapse, and remodeling, often leading to inefficient exhalation and ...
openaire +1 more source